Graham Capital Management L.P. Purchases New Position in Alignment Healthcare, Inc. $ALHC

Key Points

• Graham Capital Management L.P. acquired 28,906 shares of Alignment Healthcare, valued at approximately $538,000, indicating growing institutional interest in the company.
• Analysts have mixed views on Alignment Healthcare with ratings varying from "underweight" to "strong-buy," and the average target price for the stock is $18.83.
• Despite a recent stock decline of 2.7%, Alignment Healthcare reported a significant 49.0% year-over-year revenue increase in its latest earnings, outperforming analysts' expectations.

Graham Capital Management L.P. acquired a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 28,906 shares of the company's stock, valued at approximately $538,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ALHC. MCF Advisors LLC boosted its position in shares of Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after buying an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Alignment Healthcare during the first quarter worth approximately $42,000. Amalgamated Bank boosted its position in shares of Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after buying an additional 616 shares during the period. Tower Research Capital LLC TRC boosted its position in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after buying an additional 6,286 shares during the period. Finally, Voloridge Investment Management LLC acquired a new position in shares of Alignment Healthcare during the fourth quarter worth approximately $189,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Insider Transactions at Alignment Healthcare

In related news, Director Joseph S. Konowiecki sold 25,000 shares of the stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $16.00, for a total value of $400,000.00. Following the completion of the sale, the director directly owned 1,152,049 shares of the company's stock, valued at approximately $18,432,784. This represents a 2.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of the business's stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $13.44, for a total transaction of $403,200.00. Following the transaction, the president directly owned 2,042,899 shares in the company, valued at $27,456,562.56. The trade was a 1.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 425,923 shares of company stock worth $6,068,022. 6.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have weighed in on ALHC. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $9.00 to $13.00 in a research report on Thursday, July 31st. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a report on Monday, August 25th. Zacks Research raised shares of Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Alignment Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare Trading Down 0.1%

Shares of NASDAQ:ALHC traded down $0.02 during mid-day trading on Wednesday, hitting $16.46. The stock had a trading volume of 3,006,686 shares, compared to its average volume of 3,022,014. Alignment Healthcare, Inc. has a 12-month low of $8.82 and a 12-month high of $21.06. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market cap of $3.26 billion, a PE ratio of -58.87 and a beta of 1.17. The company's 50 day moving average is $14.27 and its 200-day moving average is $15.47.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $960.25 million. During the same period in the previous year, the company posted ($0.13) EPS. The company's quarterly revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.